Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mobilization and Outcomes After Venous Closure

NCT: NCT07246902 · ACTIVE_NOT_RECRUITING

NCT IDNCT07246902
StatusACTIVE_NOT_RECRUITING
Start Date2025-11-24
Completion2026-08-21
SponsorCordis US Corp. (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.

Frequently Asked Questions

What is Mobilization and Outcomes After Venous Closure?

Mobilization and Outcomes After Venous Closure is a clinical trial registered under NCT07246902. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07246902?

The current status of NCT07246902 (Mobilization and Outcomes After Venous Closure) is: ACTIVE_NOT_RECRUITING.

When did Mobilization and Outcomes After Venous Closure start?

Mobilization and Outcomes After Venous Closure started on 2025-11-24.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.